Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2026-06-23 17:45:02 ET · period of report 2026-06-20 · accession 0001193125-26-279833 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-23 17:45 | 2026-06-20 | LAB | Mackay Sean | SVP, Chief Business Off | A - Grant | $0.00 | +500.0K | 1.51M | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-20 | A | A | 500,000 | $0.00 | 1,506,552 | D | — | — | (F1) Represents restricted stock units ("RSUs"), 40% of which will vest on June 20, 2027, and the remaining 60% of which will vest on June 20, 2028 subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Each RSU represents the right to receive one share of common stock upon vesting. |